Korea Bone Bank to conduct clinical test over bone morphogenetic protein 2

Korea Bone Bank Corp., a local medical devices maker founded in 1997, said it will carry out a clinical trial on bone morphogenetic protein (BMP2), which stimulates bone formation. Products containing the protein are used to stimulate bone growth in patients with bone damage.

The process for producing the protein was developed by the U.S. pharmaceuticals maker Wyeth but the patent rights exp...